MONASHEE INVESTMENT MANAGEMENT, LLC


Monashee Investment Management, LLC (“Monashee” or the “Investment Manager”), was established in September 2011, and provides investment management services on a discretionary basis to certain privately offered investment vehicles and separately managed accounts. The principal owner is Monashee Holdings, LLC. which represents the interests of the managing principals, Gerald E. Coughlan and Thomas J. Wynn (the “Principals”) and LAM Holding LLC (“LAM Holding”).

Monashee Capital GP LLC and Monashee Capital GP II LLC, both Delaware limited liability companies, are the general partners (the “General Partners”) and are responsible for the overall management of the Firm’s separately managed accounts and fund-of-one vehicles. Monashee, a Delaware limited liability company, an affiliate of the General Partners, is the investment manager to the separately managed accounts and fund-of-one vehicles and is responsible for the management of the portfolios pursuant to the terms of an investment management agreement between each of the funds/accounts and the Investment Manager. Monashee Holdings, LLC is the sole member of Monashee and Monashee Capital GP LLC (“Capital GP”). The Principals indirectly control 50% of the voting interests in the Capital GP and the Investment Manager through their ownership interests in Monashee Holdings, LLC, via Fiske Road Limited Partnership are responsible for the management of the portfolios. Monashee also serves as a subadviser to an unaffiliated private fund.

All funds/accounts managed by Monashee will generally be referred to as “Clients” throughout this brochure. Monashee has full discretionary authority with respect to the investment decisions for Clients, and its advice is made in accordance with the investment objectives and guidelines as set forth in each governing document and / or investment management agreement.

As of December 31, 2019, Monashee’s discretionary regulatory assets under management were approximately $1,086,121,778. please register to get more info

Open Brochure from SEC website
Assets
Pooled Investment Vehicles $511,121,778
Discretionary $1,086,121,778
Non-Discretionary $
Registered Web Sites

Related news

BlackRock Inc. Raises Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

BlackRock Inc. raised its holdings in shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) by 1.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

$3.03 Million in Sales Expected for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) This Quarter

Brokerages forecast that AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) will post sales of $3.03 million for the current quarter, Zacks reports. Three analysts have provided estimates for AVEO Pharmaceuticals’ earnings,
Loading...
No recent news were found.